[1] Sarode GS, Sarode SC, Maniyar N, et al. Oral cancer databases: A comprehensive review [J]. J Oral Pathol Med, 2018, 47(6):547-556. [2] Chakraborty P, Karmakar T, Arora N, et al. Immune and genomic signatures in oral (head and neck) cancer [J]. Heliyon, 2018, 4(10):e880. [3] Vincent-Chong VK, Dejong H, Rich LJ, et al. Impact of age on disease progression and microenvironment in oral cancer [J]. J Dent Res, 2018, 97(11):1268-1276. [4] 徐飞,王姗,孟琰,等.SOX2在口腔鳞癌中的表达及其与EMT的相关性[J].口腔医学研究, 2017, 33(11):1209-1212. [5] 白雪校,赵丹,张杰. 北京市居民原发口腔鳞状细胞癌发病情况及相关资料分析--单中心5年连续研究[J].实用口腔医学杂志, 2017, 33(5):657-660. [6] Costa V, Kowalski LP, Coutinho-Camillo CM, et al. EGFR amplification and expression in oral squamous cell carcinoma in young adults [J]. Int J Oral Maxillofac Surg, 2018, 47(7):817-823. [7] Zhang Y, Dube C, Gibert MJ, et al. The p53 pathway in glioblastoma [J]. Cancers (Basel), 2018, 10(9). pii: E297. [8] Gasco M, Crook T. The p53 network in head and neck cancer [J]. Oral Oncol, 2003, 39(3):222-231. [9] 李一,李龙江,黄元丁,等.rAd-p53联合化学药物治疗晚期口腔癌的临床研究[J].北京口腔医学, 2009, 17(2):94-97. |